Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$66.69 USD
+0.10 (0.15%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $66.75 +0.06 (0.09%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Price, Consensus and EPS Surprise
GILD 66.69 +0.10(0.15%)
Will GILD be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for GILD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GILD
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
The Zacks Analyst Blog Highlights Abbott Laboratories, BP, Gilead Sciences, Smith-Midland and Crimson Wine
GILD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Top Analyst Reports for Abbott, BP & Gilead
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
Strength Seen in Gilead (GILD): Can Its 8.5% Jump Turn into More Strength?
Other News for GILD
IN BRIEF: Guild Esports half-year loss narrows despite drop in sales
Guild Esports Navigates Economic Headwinds with Strategic Growth
Gilead Sciences (GILD) Gets a Hold from Wells Fargo
Gilead continues to report pipeline progress, says Argus
10 Health Care Stocks Whale Activity In Today's Session